INOVIO PHARMACEUTICALS, INC. ·
INO 8-K 2026-07-31
INOVIO PHARMACEUTICALS, INC. (INO) 8-K dated 2026-07-31 — accession 0001193125-26-326785. This URL is the filing, not the INO hub.
INOVIO PHARMACEUTICALS, INC. (INO) is a biotechnology company listed on US.
INOVIO PHARMACEUTICALS, INC. filed a 8-K on 2026-07-31. Accession 0001193125-26-326785.
Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Not investment advice. The INO SEC hub lists recent forms. The stock page is the research view.